158 related articles for article (PubMed ID: 7907060)
21. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
23. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy.
Radecka E; Magnusson M; Magnusson A
Acta Radiol; 2006 Apr; 47(3):328-31. PubMed ID: 16613316
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer: Renal complications and survival after percutaneous nephrostomy.
Souza AC; Souza AN; Kirsztajn R; Kirsztajn GM
Rev Assoc Med Bras (1992); 2016; 62(3):255-61. PubMed ID: 27310550
[TBL] [Abstract][Full Text] [Related]
25. Ureteral obstruction associated with prostate cancer: the outcome after ultrasonographic percutaneous nephrostomy.
Bordinazzo R; Benecchi L; Cazzaniga A; Vercesi A; Privitera O
Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):101-6. PubMed ID: 7889041
[TBL] [Abstract][Full Text] [Related]
26. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
[TBL] [Abstract][Full Text] [Related]
27. Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy.
Chiou RK; Chang WY; Horan JJ
J Urol; 1990 May; 143(5):957-9. PubMed ID: 2329611
[TBL] [Abstract][Full Text] [Related]
28. Palliative urinary diversion in patients with advanced pelvic malignancy.
Meyer JE; Yatsuhashi M; Green TH
Cancer; 1980 May; 45(10):2698-2701. PubMed ID: 6155198
[TBL] [Abstract][Full Text] [Related]
29. Mortality and complications associated with percutaneous nephrostomy in patients with ureteral obstruction related to advanced cervical cancer.
Cardona AF; Garzón JR; Burgos E; Abenoza LM; Cortés JA; Ramos PL
J Palliat Care; 2006; 22(4):315. PubMed ID: 17263063
[No Abstract] [Full Text] [Related]
30. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications.
Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z
Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508
[TBL] [Abstract][Full Text] [Related]
31. Palliative urinary diversion for pelvic malignancy.
Brin EN; Schiff M; Weiss RM
J Urol; 1975 May; 113(5):619-22. PubMed ID: 47918
[TBL] [Abstract][Full Text] [Related]
32. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
[TBL] [Abstract][Full Text] [Related]
33. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer.
Dowling RA; Carrasco CH; Babaian RJ
Urology; 1991 Feb; 37(2):89-91. PubMed ID: 1992595
[TBL] [Abstract][Full Text] [Related]
35. Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis.
Kawano S; Komai Y; Ishioka J; Sakai Y; Fuse N; Ito M; Kihara K; Saito N
Minerva Urol Nefrol; 2016 Oct; 68(5):437-43. PubMed ID: 26554732
[TBL] [Abstract][Full Text] [Related]
36. Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction.
Tatenuma T; Tsutsumi S; Yasui M; Noguchi G; Umemoto S; Kishida T
J Palliat Med; 2020 Feb; 23(2):254-258. PubMed ID: 31834827
[No Abstract] [Full Text] [Related]
37. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
39. Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results.
Tekin MI; Aytekin C; Aygün C; PeSkircioğlu L; Boyvat F; Ozkardeş H
Urology; 2001 Dec; 58(6):919-23. PubMed ID: 11744459
[TBL] [Abstract][Full Text] [Related]
40. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
